Career Summary:  Dr. Britten is Associate Clinical Professor in the Department of Medicine, hematology/Oncology at UCLA. She is also a practicing physician at that institution, as well as at the Dumont-UCLA Liver Cancer Center in the area of Head and Neck Oncology. She serves as Co-Associate Director of the JCCC signal transduction and Therapeutics Program Area. She received her M.D. in 1992 from the University of Toronto, Faculty of Medicine. From 1993–1995, she did her internship and residency in internal medicine at the University of Western Ontario. She then worked under fellowship grants, first in medical oncology at the University of British Columbia, Vancouver (1995–1997), then in drug development at the University of Texas Medical School at San Antonio (1997–1999). Her current work and clinical practice encompass research and treatment of breast and gastrointestinal cancers.

 

Year STOP CANCER Award was received:  2002 RCDA

 

Details of research performed with funding from STOP CANCER:  Dr. Carolyn Britten's research focuses on targeted anti-cancer therapies. She is studying signal transduction inhibitors and anti-angiogenesis agents in patients with advanced malignancies and is also conducting clinical trials involving hepatocellular cancer and breast cancer.